|
|
|
| home > white papers > Protein Therapeutics - Reading Scientific Services Ltd (RSSL) |
|
|
 WHITE PAPERS |
|
Reading Scientific Services Ltd (RSSL)
|
|
Protein Therapeutics
|
|
The use of protein-based biological materials to treat patients suffering from a wide range of diseases is one of the success stories of modern medicine. The diseases treated include diabetes (insulin), growth hormone deficiencies (recombinant human growth hormone), inborn errors of metabolism (glucosylceramidase, alpha-galactosidase), and red blood cell deficiency (erythropoietin). As the market develops, the number of biopharmaceutical products both being submitted for regulatory approval and reaching the end of their patent life is increasing.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Surge of Indian biosimilars market forecast in 2019
16th April 2019: New data from CPhI shows that, despite ongoing
reputational challenges, India’s biologics market is set for robust
growth in 2019 driven by biosimilars production. The India specific
findings from CPhI’s bio league tables predict strong ‘bio growth
potential’ in India throughout 2019 in the build-up to the 13th edition
of CPhI India 2019, which will take place at the India Expo Centre in
Delhi NCR.
More info >> |
|
 |
White Papers |
 |
|
Crossing the Blood Brain Barrier (BBB): Which Route to Take?
Aptar Pharma
Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >> |
|
 |
Industry Events |
 |
CPhI & P-MEC China
18-20 June 2019, SNIEC, Shanghai, China
CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >> |
|
|
|
